News & Stories

Celebrating the 2024 Sheila Essey Award Winner

Article Header Graphics (11)

Eva Feldman, M.D., Ph.D., FAAN, has been named the 2024 recipient of the Sheila Essey Award for ALS Research. Dr. Feldman has dedicated her career to studying neurodegenerative diseases and currently serves as the University of Michigan’s James W. Albers Distinguished University Professor; Russell N. DeJong Professor of Neurology; Director, NeuroNetwork for Emerging Therapies; and Director, ALS Center of Excellence at Michigan Medicine.

The ALS Network is honored to be a sponsor of this prestigious honor that recognizes an individual who has made significant research contributions in the search for the cause, prevention of, and cure for ALS.

Presented by Jim Essey and the American Brain Foundation during the American Academy of Neurology annual meeting in April, Dr. Feldman’s scientific contributions to both fundamental and clinical neuroscience in relation to ALS along with her groundbreaking work on ALS epidemiology demonstrate her merit as a recipient of the award. Recognized as an exceptional ALS physician, Dr. Feldman has been listed in Best Doctors of America for 20 consecutive years.

“Receiving the 2024 Sheila Essey Award is an immense honor for which I am incredibly grateful,” Dr. Feldman said. “This recognition raises the critical idea of ALS prevention to the forefront, underscoring the urgency of our collective efforts in identifying risk factors of ALS, developing effective preventative measures and treatment strategies based on our understanding of these risk factors, and ultimately preventing ALS.”

Left to Right: Sheri Strahl, MPH, MBA, President and CEO, ALS Network; Eva Feldman, MD, PhD, University of Michigan; Jim Essey, President and CEO, The Tempositions Group of Companies; and Michelle Heritage, Executive Director, American Brain Foundation.

Share This Article: